EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSIO

• Conditions: patients of both sexes, aged 65-89 years and with mild-moderate essential arterial hypertension; MedDRA version: 6.1Level: PTClassification code 10020823

• Registration Number: EUCTR2004-001616-31-IT
• Lead Sponsor: SOFARMACO

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-09-28
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified